Nuzenio

Tradingview Beam Therapeutics

Tradingview Beam Therapeutics entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 7 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Beam Therapeutics Inc. Stock 12‑Month Price Target Cut to $51.07, Implies 80% Upside - TradingViewTradingView · Wed, 05 Aug 2026 14:20:06 GMTBeam Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Tue, 04 Aug 2026 12:17:19 GMTBeam Therapeutics Inc. 2Q 2026: Revenue $0.5M, EPS $(1.18) — 10-Q Summary - TradingViewTradingView · Tue, 04 Aug 2026 11:21:01 GMTBEAM: Revenue up, net loss steady, $1.2B cash supports clinical progress and pivotal filings - TradingViewTradingView · Tue, 04 Aug 2026 11:15:04 GMTBeam Therapeutics reports Q2 2026 results: $1.15B cash, $122.7M net loss - TradingViewTradingView · Tue, 04 Aug 2026 11:13:01 GMTBEAM: Strong cash position and major clinical milestones set the stage for pivotal data and filings in 2026 - TradingViewTradingView · Tue, 04 Aug 2026 11:10:41 GMTBEAM Q2'26 Earnings: revenue estimate is 16.37M USD - TradingViewTradingView · Tue, 04 Aug 2026 11:00:05 GMT

Timeline

Wed, 05 Aug 2026 14:20:06 GMTBeam Therapeutics Inc. Stock 12‑Month Price Target Cut to $51.07, Implies 80% Upside - TradingView
Tue, 04 Aug 2026 12:17:19 GMTBeam Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary - TradingView
Tue, 04 Aug 2026 11:21:01 GMTBeam Therapeutics Inc. 2Q 2026: Revenue $0.5M, EPS $(1.18) — 10-Q Summary - TradingView
Tue, 04 Aug 2026 11:15:04 GMTBEAM: Revenue up, net loss steady, $1.2B cash supports clinical progress and pivotal filings - TradingView
Tue, 04 Aug 2026 11:13:01 GMTBeam Therapeutics reports Q2 2026 results: $1.15B cash, $122.7M net loss - TradingView
Tue, 04 Aug 2026 11:10:41 GMTBEAM: Strong cash position and major clinical milestones set the stage for pivotal data and filings in 2026 - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Beam Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.